News|Articles|July 14, 2026

Q&A: What Will It Take to Reshore US Drug Manufacturing?

The API Innovation Center's Gerren McHam on China's new supply chain rules, reshoring policy, and where US drug manufacturing goes next.

For decades, America's reliance on China for the ingredients behind its medicines was treated as a slow structural problem. In 2026, it became an immediate legal one.